First test of new obesity drug in humans
NCT ID NCT06714825
Summary
This was an early-stage study to test the safety of a new drug called HS235 in people who are overweight or obese. It involved 39 healthy adults to see how their bodies processed the drug and to check for any side effects. The main goal was to gather initial safety data to see if the drug should be studied further for weight management.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Syneos Clinical Research Unit
Québec, Quebec, Canada
Conditions
Explore the condition pages connected to this study.